tradingkey.logo

TELA Bio Inc

TELA

1.890USD

+0.030+1.61%
Horário de mercado ETCotações atrasadas em 15 min
74.76MValor de mercado
PerdaP/L TTM

TELA Bio Inc

1.890

+0.030+1.61%
Mais detalhes de TELA Bio Inc Empresa
TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, and OviTex LPR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.
Informações da empresa
Código da empresaTELA
Nome da EmpresaTELA Bio Inc
Data de listagemNov 08, 2019
CEOMr. Antony Koblish
Número de funcionários209
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 08
Endereço1 Great Valley Parkway, Suite 24
CidadeMALVERN
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal19355
Telefone14843202930
Sitehttps://www.telabio.com/
Código da empresaTELA
Data de listagemNov 08, 2019
CEOMr. Antony Koblish
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
339.79K
-21.60%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
112.75K
+1318.24%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
61.37K
-27.72%
Ms. Lisa N. Colleran
Ms. Lisa N. Colleran
Independent Director
Independent Director
14.22K
+126.79%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+126.79%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+126.79%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+126.79%
Mr. Vince J. Burgess
Mr. Vince J. Burgess
Independent Director
Independent Director
--
--
Mr. Greg Firestone
Mr. Greg Firestone
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Roberto E. Cuca, J.D.
Mr. Roberto E. Cuca, J.D.
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
339.79K
-21.60%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
112.75K
+1318.24%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
61.37K
-27.72%
Ms. Lisa N. Colleran
Ms. Lisa N. Colleran
Independent Director
Independent Director
14.22K
+126.79%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+126.79%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+126.79%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
Por EmpresaUSD
Nome
Receita
Proporção
OviTex
12.11M
65.38%
OviTex PRS
6.04M
32.63%
Other
367.00K
1.98%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
OviTex
12.11M
65.38%
OviTex PRS
6.04M
32.63%
Other
367.00K
1.98%
Distribuição de ações
Atualizado em: qui, 31 de jul
Atualizado em: qui, 31 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Nantahala Capital Management, LLC
12.92%
EW Healthcare Partners
10.39%
North Run Capital, LP
9.31%
SilverArc Capital Management, LLC
7.01%
Lytton (Laurence W)
6.20%
Other
54.17%
Investidores
Investidores
Proporção
Nantahala Capital Management, LLC
12.92%
EW Healthcare Partners
10.39%
North Run Capital, LP
9.31%
SilverArc Capital Management, LLC
7.01%
Lytton (Laurence W)
6.20%
Other
54.17%
Tipos de investidores
Investidores
Proporção
Hedge Fund
41.50%
Investment Advisor
11.37%
Venture Capital
10.42%
Investment Advisor/Hedge Fund
10.10%
Individual Investor
8.40%
Research Firm
2.33%
Other
15.89%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
184
33.43M
84.52%
-6.77M
2025Q1
191
33.22M
84.09%
-7.97M
2024Q4
187
31.75M
80.76%
+976.11K
2024Q3
178
22.55M
84.95%
-6.37M
2024Q2
170
20.61M
83.03%
-5.54M
2024Q1
157
22.19M
89.70%
-5.95M
2023Q4
151
21.96M
89.44%
-4.89M
2023Q3
146
22.32M
90.91%
-4.91M
2023Q2
142
22.34M
91.32%
+1.25M
2023Q1
130
16.96M
88.34%
-4.55M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Nantahala Capital Management, LLC
5.11M
12.92%
+1.23M
+31.81%
Apr 30, 2025
EW Healthcare Partners
4.11M
10.39%
--
--
Mar 31, 2025
North Run Capital, LP
3.68M
9.31%
+1.70M
+85.75%
Mar 31, 2025
SilverArc Capital Management, LLC
2.77M
7.01%
-294.36K
-9.60%
Mar 31, 2025
Lytton (Laurence W)
2.45M
6.2%
+1.11M
+83.00%
Sep 30, 2024
Stonepine Capital Management, LLC
2.06M
5.2%
-297.87K
-12.66%
Mar 31, 2025
The Vanguard Group, Inc.
1.93M
4.87%
+52.59K
+2.80%
Mar 31, 2025
Dafna Capital Management, LLC
1.44M
3.64%
--
--
Mar 31, 2025
Grow Funds LLC
1.40M
3.54%
+1.40M
--
Jul 24, 2024
Pentwater Capital Management LP
998.75K
2.52%
-1.25K
-0.12%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
Proporção0.01%
ProShares Hedge Replication ETF
Proporção0%
iShares Russell 2000 Growth ETF
Proporção0%
iShares Russell 2000 ETF
Proporção0%
Global X Russell 2000 ETF
Proporção0%
Global X Russell 2000 Covered Call ETF
Proporção0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0%
ProShares UltraPro Russell2000
Proporção0%
Proshares Ultra Russell 2000
Proporção0%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI